Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone
Scott D. Berkowitz, Rupert Bauersachs, Michael Szarek, Mark R. Nehler, E. Sebastian Debus, Manesh R. Patel, Sonia S. Anand, Warren H. Capell, Connie N. Hess, Judith Hsia, Nicholas J. Leeper, David Brasil, Lajos Mátyás, Rafael Díaz, Marianne Brodmann, Eva Muehlhofer, Lloyd Haskell, Marc P. Bonaca
Topics & Concepts
MedicineRivaroxabanAspirinInternal medicineHazard ratioPost-thrombotic syndromeCardiologyVascular diseaseRevascularizationThrombosisVenous thrombosisSurgeryWarfarinConfidence intervalMyocardial infarctionAtrial fibrillationPeripheral Artery Disease ManagementDiagnosis and Treatment of Venous DiseasesAntiplatelet Therapy and Cardiovascular Diseases